| 1 |
32476096 | Modulation of CYP2E1 metabolic activity in a cohort of confirmed caffeine ingesting pregnant women with preterm offspring. | 2020 Jun 1 |
2 |
| 2 |
22385180 | Molecular dynamics simulations of CYP2E1. | 2012 Mar |
1 |
| 3 |
17564586 | Caffeine intake and small-for-gestational-age birth: modifying effects of xenobiotic-metabolising genes and smoking. | 2007 Jul |
1 |
| 4 |
12795773 | How useful is the "cocktail approach" for evaluating human hepatic drug metabolizing capacity using cytochrome P450 phenotyping probes in vivo? | 2003 Jun |
1 |
| 5 |
11851639 | Effect of chronic disulfiram administration on the activities of CYP1A2, CYP2C19, CYP2D6, CYP2E1, and N-acetyltransferase in healthy human subjects. | 2002 Feb |
2 |
| 6 |
11012552 | Parkinson's disease and CYP1A2 activity. | 2000 Oct |
2 |
| 7 |
9867310 | In vivo age-related changes in hepatic drug-oxidizing capacity in humans. | 1998 Aug |
1 |
| 8 |
8857078 | Biotransformation of caffeine by cDNA-expressed human cytochromes P-450. | 1996 |
1 |
| 9 |
9156694 | Evaluation of caffeine as a test drug for CYP1A2, NAT2 and CYP2E1 phenotyping in man by in vivo versus in vitro correlations. | 1996 Apr |
2 |
| 10 |
7663531 | Interaction between two probes used for phenotyping cytochromes P4501A2 (caffeine) and P4502E1 (chlorzoxazone) in humans. | 1995 Apr |
1 |
| 11 |
1302044 | Biotransformation of caffeine, paraxanthine, theobromine and theophylline by cDNA-expressed human CYP1A2 and CYP2E1. | 1992 Apr |
4 |